AUTHOREA
Log in Sign Up Browse Preprints

loading page

Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient
  • +2
  • Irtiza Sheikh,
  • David McCall,
  • Cesar Nunez,
  • Michael Roth,
  • Branko Cuglievan
Irtiza Sheikh
MD Anderson Cancer Center

Corresponding Author:[email protected]

Author Profile
David McCall
University of Texas MD Anderson
Author Profile
Cesar Nunez
MD Anderson Cancer Center
Author Profile
Michael Roth
University of Texas MD Anderson Cancer Center Children's Cancer Hospital
Author Profile
Branko Cuglievan
University of Texas MD Anderson Cancer Center
Author Profile

Peer review status:Published

30 Aug 2021Submitted to Pediatric Blood & Cancer
Show details
Hide details
30 Aug 2021Submission Checks Completed
30 Aug 2021Assigned to Editor
31 Aug 2021Reviewer(s) Assigned
03 Sep 2021Review(s) Completed, Editorial Evaluation Pending
05 Sep 2021Editorial Decision: Revise Minor
17 Sep 20211st Revision Received
17 Sep 2021Submission Checks Completed
17 Sep 2021Assigned to Editor
17 Sep 2021Review(s) Completed, Editorial Evaluation Pending
17 Sep 2021Editorial Decision: Accept
04 Oct 2021Published in Pediatric Blood & Cancer. 10.1002/pbc.29390